Clinical Medicine
关注临床医学
本年度影响因子已更新Taylor & Francis 旗下的医学与健康期领域拥有近400本相关期刊，涵盖免疫学、肿瘤医学、药学、神经学、生物学、全科医学、医学教育学等多个领域，关注基础、转化和临床的各个阶段优质研究成果。其中，超过100本期刊致力于发表临床医学实践中的创新发现、实战经验、深度理论探索和典型病例解析等内容，95%已获得影响因子！超80%已被SCI（科学引文索引）或SSCI（社会科学引文索引）权威收录!
重点学科 & 期刊列表
The European Journal of General Practice
2023 Impact Factor: 4.2
JCR Q2
Publishes open access research on medical decision-making, healthcare delivery, medical education, and research methodology for primary care practice.
International Journal of Hyperthermia
2023 Impact Factor: 3.0
JCR Q2
Publishes articles on various aspects of thermal energy and thermal therapy in clinical, biological or engineering studies involving human or animals.
OncoTargets and Therapy
2023 Impact Factor: 2.7
JCR Q3
Publishes open access molecular research on all types of cancer, including therapeutic targets and regimens, diagnosis, pathology, and novel treatments.
Cancer Investigation
2023 Impact Factor: 1.8
JCR Q3
Publishes original papers, essays, reports on new technologies, and reviews in the fields of translational and clinical oncology.It
offers accelerated publication.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Lung Cancer: Targets and Therapy | 5.1 | Q1 | 8.1 |
| Journal of Hepatocellular Carcinoma | 4.2 | Q2 | 0.5 |
| Blood and Lymphatic Cancer: Targets and Therapy | 3.9 | Q2 | 0.0 |
| Breast Cancer: Targets and Therapy | 3.3 | Q2 | 4.1 |
| International Journal of Hyperthermia | 3.0 | Q2 | 5.9 |
| OncoTargets and Therapy | 2.7 | Q3 | 9.7 |
| Cancer Management and Research | 2.5 | Q3 | 7.4 |
| Journal of Chemotherapy | 1.9 | Q3 | 3.7 |
| Cancer Investigation | 1.8 | Q3 | 3.8 |
| Pediatric Hematology and Oncology | 1.2 | Q3 | 2.6 |
Dialogues in Clinical Neuroscience
Impact Factor:
Open Access journal
publishing at the interface between clinical neuropsychiatry and the
neurosciences focussing on relevant clinical, biological, and therapeutic
aspects.
Nature and Science of Sleep
2023 Impact Factor: 3.0
JCR Q2
Publishes open access research on the neurophysiology and functions of sleep, the genetics of sleep, biological rhythms, dreaming, sleep disorders and therapy.
Expert Review of Neurotherapeutics
2023 Impact Factor: 3.4
JCR Q2
A MEDLINE-indexed journal providing expert commentary on the use of drugs and medicines in clinical neurology and neuropsychiatry. It offers accelerated publication.
Behavioral Sleep Medicine
2023 Impact Factor: 2.2
JCR Q3
Focuses on sleep disorders, sleep-related symptoms, insomnia and associated behavioural, cognitive, emotional, physiological and mental health problems.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Expert Review of Neurotherapeutics | 3.4 | Q2 | 7.0 |
| Nature and Science of Sleep | 3.0 | Q2 | 5.7 |
| Neuropsychiatric Disease and Treatment | 2.5 | Q2 | 5.5 |
| Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration | 2.5 | Q2 | 5.4 |
| Journal of Pain Research | 2.5 | Q2 | 4.5 |
| Behavioral Sleep Medicine | 2.2 | Q3 | 7.2 |
| Topics in Stroke Rehabilitation | 2.2 | Q1 | 5.1 |
| CRANIO® | 2.0 | Q2 | 4.5 |
| The Journal of Spinal Cord Medicine | 1.8 | Q3 | 4.2 |
| Neurological Research | 1.7 | Q3 | 3.6 |
| Research and Practice in Intellectual and Developmental Disabilities | 1.7 | Q2 | 2.6 |
| Brain Injury | 1.5 | Q3 | 3.5 |
| Developmental Neurorehabilitation | 1.1 | Q3 | 3.1 |
| British Journal of Neurosurgery | 1.0 | Q3 | 2.3 |
| Neuro-Ophthalmology | 0.8 | Q4 | 1.8 |
| Dialogues in Clinical Neuroscience | -未更新 | -未更新 | 19.3 |
| The Neurodiagnostic Journal | / | / | 1.0 |
Climacteric
2023 Impact Factor: 2.9
JCR Q1
Climacteric publishes research into menopause, climacteric and mid-life health, including counselling and education of peri- and post- menopausal women.
Journal of Psychosomatic Obstetrics & Gynecology
2023 Impact Factor: 2.1
JCR Q2
Focuses on psychosomatic and psychosocial aspects of women’s health in various disciplines such as gynecology, obstetrics, nursing, psychiatry and psychology.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Climacteric | 2.9 | Q1 | 5.5 |
| Human Fertility | 2.1 | Q2 | 3.3 |
| Gynecological Endocrinology | 2.0 | Q2 | 4.4 |
| The Journal of Maternal-Fetal & Neonatal Medicine | 1.9 | Q3 | 3.7 |
| The European Journal of Contraception & Reproductive Health Care | 1.7 | Q3 | 4.4 |
| Hypertension in Pregnancy | 1.5 | Q3 | 3.4 |
| Journal of Obstetrics and Gynaecology | 0.9 | Q4 | 2.4 |
International Journal of Audiology
2023 Impact Factor: 1.8
JCR Q2
An international journal publishing research into audiology and hearing sciences including psychoacoustics, hearing impairment and rehabilitation devices.
Clinical, Cosmetic and Investigational Dentistry
2023 Impact Factor: 1.5
JCR Q3
Publishes open access research on dentistry, focusing on cosmetic intervention, including novel materials, techniques and devices, surgery, and orthodontics.
Clinical and Experimental Optometry
2023 Impact Factor: 1.7
JCR Q3
Publishes research in optometry and vision science, including clinical refraction, spectacle and contact lenses, eye disease, and ocular therapeutics.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Seminars in Ophthalmology | 1.9 | Q2 | 3.2 |
| International Journal of Audiology | 1.8 | Q2 | 4.9 |
| Clinical Ophthalmology | 1.8 | Q3 | 4.1 |
| Clinical and Experimental Optometry | 1.7 | Q3 | 4.1 |
| Clinical, Cosmetic and Investigational Dentistry | 1.5 | Q3 | 3.9 |
| International Journal of Speech-Language Pathology | 1.4 | Q2 | 3.1 |
| Clinical Optometry | 1.4 | Q3 | 3.0 |
| Cochlear Implants International | 1.4 | Q2 | 3.1 |
| Acta Oto-Laryngologica | 1.2 | Q3 | 2.5 |
| Ophthalmic Genetics | 1.2 | Q3 | 2.4 |
| Speech, Language and Hearing | 1.0 | Q3 | 2.3 |
| Orbit | 0.9 | Q4 | 2.4 |
| Strabismus | 0.8 | Q4 | 1.6 |
| Clinical and Investigative Orthodontics | 0.5 | Q4 | 0.7 |
| Acta Oto-Laryngologica Case Reports | 0.3 | Q4 | / |
Psychology Research and Behavior Management
2023 Impact Factor: 2.8
JCR Q1
Publishes open access research on behavioral, cognitive and social neuroscience, psychophysiology, behavior management and learning.
International Journal of Psychiatry in Clinical Practice
2023 Impact Factor: 2.9
JCR Q2
Focuses on mental health, neuropsychopharmacology, neuropsychiatry, clinical neurophysiology, psychotherapy, addiction, depression, anxiety and schizophrenia.
Psychology, Health & Medicine
2023 Impact Factor: 2.3
JCR Q2
Publishes research on human factors in health and illness, biopsychosocial approaches to medical care and management, and psychology and health in practice.
Journal of Psychoactive Drugs
2023 Impact Factor: 2.1
JCR Q2
Focuses on drug abuse, dependence, addiction, rehabilitation and research, hallucinogens, psychotherapy and counseling of individuals and families.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| International Journal of Transgender Health | 10.5 | Q1 | 10.4 |
| The World Journal of Biological Psychiatry | 3.0 | Q2 | 7.0 |
| International Journal of Psychiatry in Clinical Practice | 2.9 | Q2 | 6.0 |
| Psychology Research and Behavior Management | 2.8 | Q1 | 4.5 |
| Journal of Sex Research | 2.7 | Q1 | 7.0 |
| The American Journal of Drug and Alcohol Abuse | 2.7 | Q2 | 4.7 |
| Psychology, Health & Medicine | 2.3 | Q2 | 6.2 |
| International Journal of Sexual Health | 2.2 | Q1 | 3.0 |
| Journal of Psychosomatic Obstetrics & Gynecology | 2.1 | Q2 | 6.1 |
| Journal of Psychoactive Drugs | 2.1 | Q2 | 5.3 |
| Behavioral Medicine | 2.0 | Q3 | 5.3 |
| Substance Use & Misuse | 1.8 | Q3 | 3.2 |
| Issues in Mental Health Nursing | 1.7 | Q2 | 3.3 |
| Journal of Addictive Diseases | 1.6 | Q3 | 4.3 |
| Journal of Dual Diagnosis | 1.5 | Q3 | 4.9 |
| Nordic Journal of Psychiatry | 1.5 | Q3 | 3.6 |
| Children’s Health Care | 0.7 | Q4 | 1.3 |
| Journal of Occupational Therapy, Schools & Early Intervention | 0.7 | Q4 | 1.9 |
Critical Reviews in Clinical Laboratory Sciences
2023 Impact Factor: 6.6
JCR Q1
Publishes reviews on clinical laboratory aspects of biochemistry, microbiology, pathology, transfusion medicine, genetics, immunology and molecular diagnostics.
Biomarkers
2023 Impact Factor: 2.0
JCR Q3
Accepts studies on humans/animals on biomarkers of disease, exposure, response and susceptibility, focusing on relationships between markers and effects. It
offers accelerated publication.
| 期刊名称 | 影响因子 | JCR最佳分区 | CiteScore |
|---|---|---|---|
| Critical Reviews in Clinical Laboratory Sciences | 6.6 | Q1 | 20.0 |
| Expert Opinion on Biological Therapy | 3.6 | Q2 | 8.6 |
| Biomarkers | 2.0 | Q3 | 5.0 |
| Growth Factors | 1.8 | Q4 | 2.6 |
| Experimental Lung Research | 1.5 | Q3 | 3.8 |
| Scandinavian Journal of Clinical and Laboratory Investigation | 1.3 | Q4 | 3.5 |
| Hemoglobin | 1.2 | Q4 | 1.7 |
Expert Review of Clinical Immunology
2023 Impact Factor: 3.9
JCR Q2
A MEDLINE-indexed, peer-reviewed journal providing the latest research on the performance of new therapeutic and diagnostic modalities in clinical immunology. This journal offers accelerated publication.
Clinical Epidemiology
2023 Impact Factor: 3.4
JCR Q1
Publishes open access research on epidemiology and clinical care, including electronic records, data-gathering, diagnostic procedures and predictive markers.
Immunological Medicine
2023 Impact Factor: 2.7
JCR Q2
Advances in the field of clinical immunology including autoimmune and infectious diseases that require immunological approaches from various medical fields.
The European Journal of General Practice
2023 Impact Factor: 2.3
JCR Q2
Publishes open access research on medical decision-making, healthcare delivery, medical education, and research methodology for primary care practice.
医学与健康及其他各学科高水平国际期刊，请访问 Taylor & Francis Group 旗下学术期刊网站， 欢迎相关学科研究人员向您青睐的杂志投稿。
期刊网站：www.tandfonline.com
选择加速出版
如果时间对于您至关重要，我们部分医学与健康及药学期刊提供加速出版服务。我们将通过投入额外的资源来监控和管理同行评审流程，满足紧迫的周转时间要求，帮助您快速发表研究成果。
为期刊、图书作者提供的实用指南
在您准备撰写一篇国际学术论文时，一个为您提供必要指导和资源实用网站可以为您解答许多疑问！从选刊、写作、投稿、同行评审、出版等各个方面给予详细的指导，写作投稿前的必看网站！
拥抱开放科学
开放获取对于作者、读者而言极具价值，开放科学让研究在更广泛的维度得到参考和使用，提升研究可见度和影响力，造福社会。您是否考虑发表开放获取文章？点击了解开放获取出版更多信息
联系我们
Taylor & Francis Group拥有220多年的历史，是全球领先的学术出版集团，业务包括学术期刊、图书、电子书、教科书和参考书。以高质量的学术内容和服务水平，每年出版期刊2600余种，新书7000余册，累计图书出版量15万余册。旗下包括Routledge, CRC Press, Taylor & Francis等品牌，实现全学科均衡覆盖。我们整合数据、资源和技术优势，愿为中国研究人员和中国开放科学的发展提升，贡献更多的智慧和力量。